IDENTIFYING RISK FACTORS FOR THE SPREAD OF DRUG-RESISTANT TUBERCULOSIS IN LAMPUNG IN 2023: A CASE-CONTROL STUDY
Analisis Faktor Risiko Penyebaran Tuberkulosis Resisten Obat di Provinsi Lampung Tahun 2023
![](https://e-journal.unair.ac.id/public/journals/74/submission_61517_59684_coverImage_en_US.png)
Downloads
Background: Drug-resistant tuberculosis (DR-TB) is a growing health concern in Lampung, where the low rate of DR-TB case detection and high treatment failure rates emphasize the necessity of identifying risk factors to strengthen control measures for DR-TB. Purpose: This study aimed to identify the dominant risk factors for the spread of drug-resistant tuberculosis among patients in Lampung Province in 2023. Methods: Using a case-control study design, the research utilized secondary data from the Tuberculosis Information System (SITB) Lampung Province. A total sampling method was employed, with 126 respondents in the case group and a 1:1 ratio, making the total sample size 252 respondents. Data matching was done for gender and age variables. Statistical analysis included univariate, bivariate chi-square, and multivariate logistic regression tests. Results: Univariate analysis showed that 57.90% of respondents were male, 57.90% were in the at-risk age group, 58.30% were employed, 81.30% did not have diabetes (DM) comorbidity, 97,20% did not have HIV comorbidity, 67,50% had no prior TB treatment history. Bivariate analysis indicated significant associations with occupation (p-value 0.04), DM comorbidity (p-value 0.02), and treatment history (p-value 0.00). Gender, age, and HIV comorbidity showed no significant associations. The multivariate analysis showed a significant effect of the TB treatment history variable (p-value 0.00, OR=9.04) and the HIV comorbidity variable (p-value 0.03, OR= 0.08). Conclusion: TB treatment history is the dominant factor that can affect the spread of drug-resistant tuberculosis in Lampung Province in 2023. Future researchers are encouraged to focus on studying the types of treatment failures.
Ministry of Health of the Republic of Indonesia. Report on the 2022 Tuberculosis Control Program [Internet]. Jakarta; 2023.
WHO. Global Tuberrculosis report 2022 [Internet]. 2022.
South Lampung District Health Office. Health profile of South Lampung district in 2022 [Internet]. Lampung Selatan; 2022.
Khawbung JL, Nath D, Chakraborty S. Drug resistant Tuberculosis: A review. Comp Immunol Microbiol Infect Dis. 2021;74:101574.
Ntuli TT. Socio-economic risk factors for acquired Multi drug-resistant Tuberculosis among tuberculosis patients in South Africa, Tshwane Health District: A Retrospective Study. University of Johannesburg (South Africa); 2022.
Wahyuni T, Cahyati WH. Multidrug resistant Tuberculosis (MDR-TB). HIGEIA (Journal Public Heal Res Dev [Internet]. 2020;4(Special 3):636–48.
Mehari K, Asmelash T, Hailekiros H, Wubayehu T, Godefay H, Araya T, et al. Prevalence and factors associated with Multidrug-Resistant Tuberculosis (MDR-TB) among presumptive MDR-TB patients in Tigray Region, Northern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019.
Sutrisna M, Elsi Rahmadani. Relationship between age and gender with MDR TB. Sehat Rakyat J Kesehat Masy. 2022 Nov;1(4):370–6.
Rajendran M, Zaki RA, Aghamohammadi N. Contributing risk factors towards the prevalence of multidrug-resistant tuberculosis in Malaysia: A systematic review. Tuberculosis. 2020;122:101925.
Aristiana CD, Wartono M. Faktor-faktor yang mempengaruhi kejadian multi drug resistance tuberkulosis (MDR-TB). J Biomedika Dan Kesehat [Internet]. 2018;1(1):65–74.
Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Front Physiol. 2021;11:571416.
Nolt D, Starke JR, Diseases C on I. Tuberculosis infection in children and adolescents: testing and treatment. Pediatrics. 2021;148(6).
Caraux-Paz P, Diamantis S, de Wazières B, Gallien S. Tuberculosis in the elderly. J Clin Med. 2021;10(24):5888.
Laycock KM, Enane LA, Steenhoff AP. Tuberculosis in adolescents and young adults: Emerging data on TB transmission and prevention among vulnerable young people. Trop Med Infect Dis. 2021;6(3):148.
Etim NG, Mirabeau Y, Olorode A, Nwodo U. Risk factors of Tuberculosis and strategies for prevention and control. Int J Innov Healthc Res. 2024;12(1):1–13.
Feng M, Xu YG, Zhang XY, Qiu Q, Lei SG, Li JL, et al. Risk factors of multidrug-resistant tuberculosis in China: A meta-analysis. Public Health Nurs. 2019 May;36(3):257–69.
Al Qarni Bayan U. Characteristics of drug-resistant tuberculosis patients at dr. H. Chasan Boesoirie Regional Hospital. Kieraha Med J. 2022;4(2):116–23.
Manggasa DD, Suharto DN. History of diabetes mellitus treatment and comorbidities are associated with the incidence of drug-resistant tuberculosis.. Poltekita J Ilmu Kesehat. 2022;15(4):403–8.
Mahartati NMN, Syahrizal Syarif. Risk factors for tuberculosis treatment failure: a systematic review. Media Publ Promosi Kesehat Indones. 2024 Apr;7(4):899–906.
Keng Tok PS, Liew SM, Wong LP, Razali A, Loganathan T, Chinna K, et al. Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study. PLoS One. 2020;15(4):1–14.
Yunita S, Nurfadhilah N, Srisantyorini T, Herdiansyah D. Spatial analysis of Tuberculosis incidence based on physical environment. Environ Occup Heal Saf J. 2022;3(1):1–10.
Chávez-Reyes J, Escárcega-González CE, Chavira-Suárez E, León-Buitimea A, Vázquez-León P, Morones-Ramírez JR, et al. Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia. Front public Heal. 2021;9:559595.
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.